ArticleAnti-cancer drugs2017

In-vitro and in-vivo combined effect of ARQ 092, an AKT inhibitor, with ARQ 087, a FGFR inhibitor.

Yi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.